While tumor cells do not have high expression of NFE2L2 relative to myeloid cells, elevated expression occurs downstream of the Nrf2 pathway (NQO1, GPX2), which regulates oxidative damage repair (Fig. 8a). Here, NFE2L2 is linked to neoplasm.